New research has found specialist nursing support for Australian men on hormone therapies for prostate cancer may help to reduce higher risks of suicide and improve quality of life for men impacted by the disease.
New national guidelines for PSA testing and the early detection of prostate cancer provide updated guidance on who should be offered testing, how frequently testing should occur and what should happen when PSA levels are elevated. The guidelines aim to support earlier detection while ensuring testing and investigation are based on individual risk and informed decision-making.
In Australia, Prostate cancer (PCa) has a high survival rate (96%) meaning men with PCa may live with the impact of the disease for many years, even decades. The Prostate Cancer Foundation of Australia (PCFA) manages two Prostate Cancer Specialist Nursing (PCSN) programs: (1) A health service-based program and (2) A telenursing service. There is a paucity of economic evidence regarding the benefits of these programs so Social Return on Investment (SROI) methodology was used to determine social value and return on investment.
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
Cancer Council has updated cancer publications: Understanding Primary Bone Cancer, Nutrition and Cancer, Understanding Testicular Cancer, Sex, Intimacy & Cancer.
